Egetis Therapeutics AB (EGTX) Stock Forecast & Price Target
― Followers
See the Price Targets and Ratings of:
EGTX Analyst Ratings
Currently, no data available
Based on NaN analysts giving stock ratings to
Egetis
Therapeutics AB
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
EGTX Stock 12 Month Forecast
There Are No Analyst Ratings for SE:EGTX In The Last 3 Months.
Highest Price Target―
Average Price Target―
Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
EGTX Financial Forecast
EGTX Earnings Forecast
The previous quarter’s earnings for EGTX were -kr0.24.
The previous quarter’s earnings for EGTX were -kr0.24.
EGTX Sales Forecast
Next quarter’s sales forecast for EGTX is kr21.80M with a range of kr21.80M to kr21.80M. The previous quarter’s sales results were kr13.40M. EGTX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year EGTX has Performed in-line its overall industry.
Next quarter’s sales forecast for EGTX is kr21.80M with a range of kr21.80M to kr21.80M. The previous quarter’s sales results were kr13.40M. EGTX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year EGTX has Performed in-line its overall industry.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.
EGTX Analyst Recommendation Trends
Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
0
0
In the current month, EGTX has received 0Buy Ratings, 0Hold Ratings, and 0Sell Ratings. EGTX average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.
EGTX Stock Forecast FAQ
What is SE:EGTX’s average 12-month price target, according to analysts?
Currently, no data Available
What is SE:EGTX’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for SE:EGTX, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Egetis Therapeutics AB a Buy, Sell or Hold?
Currently, no data Available
What is Egetis Therapeutics AB’s share price target?
Currently, no data Available
What do analysts say about Egetis Therapeutics AB?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Egetis Therapeutics AB?
To buy shares of SE:EGTX, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.